To determine whether patients with unexplained recurrent pregnancy loss (URPL) can benefit from pre‐conception immunotherapy or on the early phase of the first trimester. Click to show full abstract
To determine whether patients with unexplained recurrent pregnancy loss (URPL) can benefit from pre‐conception immunotherapy or on the early phase of the first trimester.
               
Click one of the above tabs to view related content.